Real-time trading and investing news feed: PRs, earnings, patent approvals, FDA approvals, mergers, insider trades, analyst ratings, SEC filings, unusual trading vol, and more. Not investment advice.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.